⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALNY News
Alnylam Pharmaceuticals, Inc.
Marine Biological Laboratory Expands Board of Trustees as It Charts Its Next Chapter as an Independent Institution
prnewswire.com
IRWD
ALNY
PULM
Graph AI Raises $13.3M Series A to Scale the First AI-Native Operating System for Patient Safety
prnewswire.com
NVDA
GOOG
MSFT
AMZN
META
IBM
ORCL
CRM
ADBE
INTC
AMD
QCOM
AMAT
MU
SMCI
ASML
LRCX
KLAC
TER
SNPS
CDNS
PANW
CRWD
DDOG
PLTR
SNOW
AI
UPST
SOFI
COIN
RIOT
MARA
PLUG
FCEL
ROKU
NFLX
DIS
CMCSA
TCOM
BABA
JD
PDD
NIO
LI
TSLA
RIVN
LCID
GM
F
STLA
VWAGY
HON
GE
BA
LMT
RTX
GD
NOC
AVAV
KBR
BWXT
XOM
CVX
SHEL
BIDU
NET
FTNT
CSCO
HPQ
DELL
LEN
DHI
NVR
PHM
TMHC
MTH
KBH
BKH
ESNT
MTG
WFG
RGA
AGNC
TWO
PSEC
ARCC
BX
KKR
APO
CME
ICE
MSCI
SPGI
EQIX
AMKR
WDC
SE
MELI
AMGN
GILD
BMY
PFE
MRK
LLY
ABBV
REGN
VRTX
BIIB
AZN
SNY
NVS
ROG
TEVA
BHC
ALKS
IRTC
EXAS
CRIS
EDIT
NTLA
BNTX
MRNA
ALNY
BTAI
NVO
LULU
SIRI
SPOT
PTON
GOOGL
ZS
XPEV
$651 Million Aptamers Market Assessment and Outlook, 2032 | Chemical Engineering, Targeted Delivery, and AI-Assisted Discovery are Major Growth Catalysts
globenewswire.com
AGNC
BIIB
REGN
ALNY
CRSP
GILD
AMGN
BMY
MRK
PFE
JNJ
ABBV
LLY
AZN
NVS
SNY
TEVA
BSX
MDLZ
GOOG
MSFT
IBM
NVDA
INTC
AMD
QCOM
AMZN
CRM
ORCL
SAP
ADBE
GOOGL
META
NFLX
DIS
CMCSA
VZ
T
XOM
CVX
KO
PEP
MCD
SBUX
COST
WMT
BABA
JD
BIDU
NTES
PDD
SIRI
AMC
GME
TSLA
NIO
RIVN
LCID
F
GM
STLA
TM
HON
GE
BA
LMT
RTX
GD
CAT
DE
MMM
DOW
DD
LULU
NKE
HD
LOW
SPG
PLD
AMT
EQIX
PLTR
SNOW
DDOG
CRWD
PANW
ZS
FTNT
VRTX
Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer
globenewswire.com
GILD
ALNY
2026 RNAi Therapeutics Market Report (3rd Edition): Analysis by Type of RNAi Molecule, Therapeutic Area, Route of Administration, Key Geographical Regions, Sales Forecast and Leading Industry Players to 2035
globenewswire.com
ALNY
ARWR
NVO
NVS
BIIB
REGN
GILD
MRK
BMY
ABBV
AMGN
AZN
PFE
SNY
TEVA
BHC
CRSP
EDIT
NTLA
SRPT
SLN
Hereditary Transthyretin Amyloidosis Market Insight, Epidemiology, and Market Forecast - 2036 Now Available Reveals Why a $3B Market Is Racing Toward a One-Time Curative Gene-Editing Therapy
globenewswire.com
NTLA
REGN
ALNY
IONS
PFE
Alnylam présente de nouvelles données lors du congrès de l’ESC 2026, qui confirment l’efficacité de l’inhibition de la TTR par ARNi chez les populations de patients atteints d’ATTR-CM et dans différents contextes thérapeutiques
businesswire.com
ALNY
Alnylam präsentiert auf dem ESC Congress 2026 neue Daten, die die Wirksamkeit des RNAi-basierten TTR-Silencing bei verschiedenen ATTR-CM-Patientengruppen und in verschiedenen Behandlungsumgebungen belegen
businesswire.com
ALNY
Alnylam presenta nuevos datos en el Congreso 2026 de la ESC que refuerzan la eficacia en el silenciamiento de la transtiretina mediante interferencia de ARN en poblaciones de pacientes y entornos de tratamiento de miocardiopatía amiloide por trans...
businesswire.com
ALNY
Alnylam presenteert nieuwe gegevens op het ESC-congres 2026 en legt de nadruk op de effectiviteit van RNAi-gebaseerde TTR-silencing bij verschillende ATTR-CM-patiëntengroepen
businesswire.com
ALNY